At the news
? NEUTRALIMPACT 2/10 144 filed Nov 13, 2026 at 13:02 ET
Paul Andrew Moore, an officer of Zymeworks, filed a Form 144 notice of intent to sell 39,741 shares of common stock worth approximately $1.05 million. The shares were acquired through vesting of restricted stock units and exercise of options. The sale is small relative to the company's $2.0 billion market cap (about 0.05%) and appears to be a routine exercise-and-sell-to-cover transaction for tax obligations.
- Reporting person: Paul Andrew Moore, an officer of Zymeworks Inc.
- Shares to be sold: 39,741 shares of common stock
- Approximate dollar value: $1,051,944.27
- Shares acquired via vesting of RSUs (Jan 2024, Jan 2025) and exercise of options (Nov 2026)
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access